Didem Saygın

1.2k total citations
48 papers, 502 citations indexed

About

Didem Saygın is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Didem Saygın has authored 48 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Neurology. Recurrent topics in Didem Saygın's work include Inflammatory Myopathies and Dermatomyositis (27 papers), Parkinson's Disease and Spinal Disorders (9 papers) and Muscle Physiology and Disorders (8 papers). Didem Saygın is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (27 papers), Parkinson's Disease and Spinal Disorders (9 papers) and Muscle Physiology and Disorders (8 papers). Didem Saygın collaborates with scholars based in United States, Sweden and Australia. Didem Saygın's co-authors include Kristin B. Highland, Adriano R. Tonelli, Chester V. Oddis, Rohit Aggarwal, Siamak Moghadam‐Kia, Diane Koontz, Robyn T. Domsic, W.H. Wilson Tang, Serpil C. Erzurum and Samar Farha and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Didem Saygın

40 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didem Saygın United States 14 221 150 117 106 82 48 502
Can Huang China 13 240 1.1× 120 0.8× 124 1.1× 100 0.9× 112 1.4× 70 651
Matthieu Canuet France 15 665 3.0× 149 1.0× 130 1.1× 216 2.0× 72 0.9× 48 934
Oğuz Dikbaş Türkiye 13 71 0.3× 106 0.7× 61 0.5× 73 0.7× 50 0.6× 29 566
Gene‐Siew Ngian Australia 14 244 1.1× 112 0.7× 85 0.7× 68 0.6× 420 5.1× 47 677
Cemal Beş Türkiye 11 84 0.4× 78 0.5× 72 0.6× 31 0.3× 66 0.8× 68 464
Dyanne Rampling United Kingdom 12 126 0.6× 75 0.5× 126 1.1× 43 0.4× 53 0.6× 20 593
Álfio José Tincani Brazil 14 129 0.6× 91 0.6× 72 0.6× 39 0.4× 78 1.0× 70 700
Xiaoye Lu China 11 104 0.5× 194 1.3× 47 0.4× 25 0.2× 79 1.0× 22 419
Mehmet Demir Türkiye 14 111 0.5× 70 0.5× 40 0.3× 265 2.5× 77 0.9× 81 695

Countries citing papers authored by Didem Saygın

Since Specialization
Citations

This map shows the geographic impact of Didem Saygın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didem Saygın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didem Saygın more than expected).

Fields of papers citing papers by Didem Saygın

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didem Saygın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didem Saygın. The network helps show where Didem Saygın may publish in the future.

Co-authorship network of co-authors of Didem Saygın

This figure shows the co-authorship network connecting the top 25 collaborators of Didem Saygın. A scholar is included among the top collaborators of Didem Saygın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didem Saygın. Didem Saygın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saygın, Didem, Anne‐Marie Malfait, Ethan Ritz, et al.. (2025). Prevalence of Pain and Factors Associated With Pain in Patients With Idiopathic Inflammatory Myopathies. Arthritis Care & Research. 78(1). 134–140.
2.
Falconer, Thomas, Elizabeth Park, David Fiorentino, et al.. (2025). Identification of Adult Patients With Dermatomyositis Using Real‐World Data Sources. Arthritis Care & Research. 78(3). 362–370.
3.
Aggarwal, Rohit, Siamak Moghadam‐Kia, Sangmee Bae, et al.. (2025). Abatacept for the treatment of myositis-associated interstitial lung disease. Lara D. Veeken. 64(SI). SI156–SI168. 2 indexed citations
5.
Saygın, Didem, Victoria P. Werth, Julie J. Paik, et al.. (2024). Response to: Correspondence on ‘Current myositis clinical trials and tribulations’ by Saygin et al. Annals of the Rheumatic Diseases. 83(11). e23–e23. 1 indexed citations
6.
Saygın, Didem, Helene Alexanderson, Dana DiRenzo, et al.. (2024). The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group. Seminars in Arthritis and Rheumatism. 67. 152476–152476. 2 indexed citations
7.
Saygın, Didem, et al.. (2024). A patient-centred assessment of the 2016 ACR-EULAR Myositis Response Criteria: evaluating the meaningfulness of responses. Lara D. Veeken. 64(3). 1355–1361. 1 indexed citations
8.
Leverenz, David, et al.. (2023). RheumMadness: Creating an Online Community of Inquiry in Rheumatology. Arthritis Care & Research. 75(11). 2248–2258. 1 indexed citations
9.
Saygın, Didem, Matteo Bottai, Marjolein Visser, et al.. (2023). Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review. Clinical and Experimental Rheumatology. 42(2). 403–412. 4 indexed citations
10.
Saygın, Didem & Chester V. Oddis. (2022). Glucocorticoids in Myositis: Initiation, Tapering, and Discontinuation. Current Rheumatology Reports. 24(3). 47–53. 4 indexed citations
11.
Fernandez‐Ruiz, Ruth, Alí Duarte‐García, Sebastian E. Sattui, et al.. (2022). Supporting International Medical Graduates in Rheumatology: A Call to Action. Arthritis & Rheumatology. 75(2). 145–148.
13.
Saygın, Didem, Bonny Rockette‐Wagner, Chester V. Oddis, et al.. (2021). Consumer-based activity trackers in evaluation of physical activity in myositis patients. Lara D. Veeken. 61(7). 2951–2958. 17 indexed citations
14.
Rockette‐Wagner, Bonny, Didem Saygın, Siamak Moghadam‐Kia, et al.. (2021). Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy. Lara D. Veeken. 60(12). 5713–5723. 23 indexed citations
15.
Arslan, Esra, et al.. (2021). Factors affecting pathological complete response after neoadjuvant chemotherapy in breast cancer: a single-center experience. Revista da Associação Médica Brasileira. 67(6). 845–850. 3 indexed citations
16.
Saygın, Didem, Chester V. Oddis, Galina Marder, et al.. (2020). Follow-up results of myositis patients treated with H. P. Acthar gel. Lara D. Veeken. 59(10). 2976–2981. 8 indexed citations
17.
Saygın, Didem, Chester V. Oddis, Siamak Moghadam‐Kia, et al.. (2020). Hand-held dynamometry for assessment of muscle strength in patients with inflammatory myopathies. Lara D. Veeken. 60(5). 2146–2156. 17 indexed citations
18.
Saygın, Didem, Tracy Tabib, Humberto E. Trejo Bittar, et al.. (2020). Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension. Pulmonary Circulation. 10(1). 1–15. 67 indexed citations
19.
Saygın, Didem, et al.. (2019). Pulmonary Arterial Hypertension In Systemic Sclerosis: Challenges In Diagnosis, Screening And Treatment. SHILAP Revista de lepidopterología. 3 indexed citations
20.
Saygın, Didem, Kristin B. Highland, & Adriano R. Tonelli. (2018). Microvascular involvement in systemic sclerosis and systemic lupus erythematosus. Microcirculation. 26(3). e12440–e12440. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026